Evidence map›Paper›PMID 21609822›Full record

ReviewNeuron2011

Deriving excitatory neurons of the neocortex from pluripotent stem cells.

David V Hansen, John L R Rubenstein, Arnold R Kriegstein

Open access · bronzeAbstract readReview
In one paragraph

Review in Neuron, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 119 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Screening Platforms for Genetic Epilepsies-Zebrafish, iPSC-Derived Neurons, and Organoids.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

David V HansenDepartment of Neurology, University of California, San Francisco, CA 94143, USA.
John L R Rubenstein
Arnold R Kriegstein
University of California, San Francisco · US

Funding

INTERCELLULAR SIGNALLING IN NEOCORTICAL DEVELOPMENTR01NS021223 · NINDS · YALE UNIVERSITY · PI KRIEGSTEIN, ARNOLD · 1985 to 2011
$3.9M
Stem Cells of the Developing Human NeocortexR01NS075998 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRIEGSTEIN, ARNOLD · 2011 to 2016
$1.8M
Molecular and cellular mechanism of MicrocephalyR01NS072630 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRIEGSTEIN, ARNOLD · 2010 to 2014
$1.6M
NINDS NIH HHS R01 NS021223NINDS NIH HHS R01 NS072630NINDS NIH HHS R01 NS075998
6 · The paper itself

Abstract

The human cerebral cortex is an immensely complex structure that subserves critical functions that can be disrupted in developmental and degenerative disorders. Recent innovations in cellular reprogramming and differentiation techniques have provided new ways to study the cellular components of the cerebral cortex. Here, we discuss approaches to generate specific subtypes of excitatory cortical neurons from pluripotent stem cells. We review spatial and temporal aspects of cortical neuron specification that can guide efforts to produce excitatory neuron subtypes with increased resolution. Finally, we discuss distinguishing features of human cortical development and their translational ramifications for cortical stem cell technologies.

Indexed as

AnimalsCell DifferentiationExcitatory Postsynaptic PotentialsHumansNeocortexNeuronsPluripotent Stem Cells

Identifiers

PMID21609822
PMCPMC3124445
OpenAlexW2067512190

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.